J-Pharma Co.,Ltd.
TTSE:520AShare Statistics
As of December 31, 2025, J-Pharma Co.,Ltd. has 17.83M shares outstanding.
| Shares Outstanding | 17.83M |
Financial Position
As of December 31, 2025, J-Pharma Co.,Ltd. maintains a current ratio of 4.88, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.88 |
| Quick Ratio | 3.94 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025. The company generates approximately - - in revenue per employee across its workforce of 11.00, a quick read on workforce productivity versus industry peers.
| Employee Count | 11.00 |
Taxes
JPYOver the twelve months ended December 31, 2025, J-Pharma Co.,Ltd. recorded 219,000.00 in income tax expense.
| Income Tax | 219,000.00 |
Stock Price Statistics
JPYThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 370.44 |
Income Statement
JPYThese figures cover the twelve months ended December 31, 2025.
| Pretax Income | -447.71M |
Balance Sheet
JPYThese figures are as of December 31, 2025. Total book value stands at 2.34B, with working capital of 2.34B providing operational flexibility.
| Cash & Cash Equivalents | 2.37B |
| Net Debt | -2.01B |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 131.50 |
| Working Capital | 2.34B |